GRA were asked by UK diagnostics development company to assist in the commercial development and fund raising activities for a diagnostic device for early detection of heart attack.
GRA worked with the founders to assemble a business case for the device producing a market assessment data and an understanding of what a device would look like within an Emergency room setting within a hospital. This case was put forward within a non-diluting government contract scheme within the UK’s NHS. After various screening rounds and interview panels and meetings with NHS health economists, over a period of 12 months GRA was successful in helping the company raise £1.1 million 100% non-dilutional funds to develop the device.
Complete your details and we’ll send you regular updates via our newsletter.
Need to understand some element of the biopharma industry or looking for a particular template?
© 2023 GreyRigge Associates Limited. All rights reserved.
Site design & build by Hinge Ltd.